Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Asthma

  Free Subscription


Articles published in Allergy

Retrieve available abstracts of 92 articles:
HTML format



Single Articles


    September 2022
  1. VAZQUEZ-ORTIZ M, Gore C, Alviani C, Angier E, et al
    A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies - an EAACI Position paper.
    Allergy. 2022 Sep 29. doi: 10.1111/all.15533.
    PubMed     Abstract available


  2. LEE-SARWAR KA, Chen YC, Chen YY, Kozyrskyj AL, et al
    The Maternal Prenatal and Offspring Early-Life Gut Microbiome of Childhood Asthma Phenotypes.
    Allergy. 2022 Sep 15. doi: 10.1111/all.15516.
    PubMed     Abstract available


  3. LIANG Q, Fu J, Wang X, Liu L, et al
    circS100A11 enhances M2a macrophage activation and lung inflammation in children with asthma.
    Allergy. 2022 Sep 14. doi: 10.1111/all.15515.
    PubMed     Abstract available


  4. RAVANETTI L, Dekker T, Guo L, Dijkhuis A, et al
    Efficacy of FP-025, a novel Matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma.
    Allergy. 2022 Sep 12. doi: 10.1111/all.15513.
    PubMed    


  5. BOURDIN A, Bommart S, Marin G, Vachier I, et al
    Obesity in women with asthma: baseline disadvantage plus greater small-airway responsiveness.
    Allergy. 2022 Sep 7. doi: 10.1111/all.15509.
    PubMed     Abstract available


  6. KOSKINEN A, Lemmetyinen R, Luukkainen A, Kankaanranta H, et al
    Season of birth affects the risk of adult-onset asthma in Finland.
    Allergy. 2022 Sep 6. doi: 10.1111/all.15504.
    PubMed    


  7. ONG HH, Andiappan AK, Duan K, Lum J, et al
    Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro.
    Allergy. 2022;77:2778-2793.
    PubMed     Abstract available


    August 2022
  8. MURPHY RC, Chow YH, Lai Y, Al-Shaikhly T, et al
    Identification of Mast Cell Progenitor Cells in the Airways of Individuals with Allergic Asthma.
    Allergy. 2022 Aug 29. doi: 10.1111/all.15498.
    PubMed    


  9. BADI YE, Salcman B, Taylor A, Rana B, et al
    IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma.
    Allergy. 2022 Aug 20. doi: 10.1111/all.15487.
    PubMed     Abstract available


  10. VAZQUEZ-MERA S, Martelo-Vidal L, Miguens-Suarez P, Saavedra-Nieves P, et al
    Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity.
    Allergy. 2022 Aug 16. doi: 10.1111/all.15480.
    PubMed     Abstract available


  11. VARRICCHI G, Ferri S, Pepys J, Poto R, et al
    Biologics and Airway Remodeling in Severe Asthma.
    Allergy. 2022 Aug 11. doi: 10.1111/all.15473.
    PubMed     Abstract available


  12. CARUSO C, Colantuono S, Ciasca G, Basile U, et al
    Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
    Allergy. 2022 Aug 3. doi: 10.1111/all.15466.
    PubMed     Abstract available


  13. MUMBY S, Kermani NZ, Garnett JP, Pavlidis S, et al
    CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
    Allergy. 2022 Aug 2. doi: 10.1111/all.15465.
    PubMed    


  14. KARLINA R, Flexeder C, Musiol S, Bhattacharyya M, et al
    Differential effects of lung inflammation on insulin resistance in humans and mice.
    Allergy. 2022;77:2482-2497.
    PubMed     Abstract available


    July 2022
  15. PAPI A, Corren J, Castro M, Domingo C, et al
    Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
    Allergy. 2022 Jul 28. doi: 10.1111/all.15456.
    PubMed     Abstract available


  16. JEONG JS, Choi JY, Kim JS, Park SO, et al
    SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation.
    Allergy. 2022 Jul 24. doi: 10.1111/all.15452.
    PubMed    


  17. HE A, Chen J, Guan J, Huang Y, et al
    Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma.
    Allergy. 2022 Jul 20. doi: 10.1111/all.15448.
    PubMed    


  18. MAGGI E, Parronchi P, Azzarone BG, Moretta L, et al
    A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15445.
    PubMed     Abstract available


  19. BENAMAR M, Harb H, Chen Q, Wang M, et al
    A Common IL-4 Receptor Variant Promotes Asthma Severity via a Treg Cell GRB2-IL-6-Notch4 Circuit.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15444.
    PubMed     Abstract available


  20. DEVRIES A, McCauley K, Fadrosh D, Fujimura KE, et al
    Maternal Prenatal Immunity, Neonatal Trained Immunity, and Early Airway Microbiota Shape Childhood Asthma Development.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15442.
    PubMed     Abstract available


  21. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
    The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma.
    Allergy. 2022 Jul 15. doi: 10.1111/all.15438.
    PubMed    


  22. NAVARATNA S, Burgess J, Waidyatillake N, Peters RL, et al
    Reply to the correspondence: Bacillus Calmette-Guerin vaccination to prevent childhood asthma-A revised analysis.
    Allergy. 2022;77:2264-2265.
    PubMed    


  23. PITTET LF, Curtis N
    Bacillus Calmette-Guerin vaccination to prevent childhood asthma: A revised meta-analysis.
    Allergy. 2022;77:2262-2263.
    PubMed    


  24. DIVER S, Haldar K, McDowell PJ, Busby J, et al
    Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
    Allergy. 2022 Jul 1. doi: 10.1111/all.15425.
    PubMed     Abstract available


  25. LEE SE, Hopkins C, Mullol J, Msihid J, et al
    Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
    Allergy. 2022;77:2211-2221.
    PubMed     Abstract available


    June 2022
  26. RADZIKOWSKA U, Baerenfaller K, Cornejo-Garcia JA, Karaaslan C, et al
    Omics technologies in allergy and asthma research: an EAACI position paper.
    Allergy. 2022 Jun 17. doi: 10.1111/all.15412.
    PubMed     Abstract available


  27. CAIT A, Wedel A, Arntz JL, Duinkerken J, et al
    Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis.
    Allergy. 2022 Jun 11. doi: 10.1111/all.15404.
    PubMed     Abstract available


  28. OWORA AH, Li R, Tepper RS, Ramsey CD, et al
    Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort.
    Allergy. 2022 Jun 10. doi: 10.1111/all.15403.
    PubMed    


  29. STARK JM, Liu J, Tibbitt CA, Christian M, et al
    A recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH 2 and TH 17 cell responses.
    Allergy. 2022 Jun 3. doi: 10.1111/all.15399.
    PubMed     Abstract available


    May 2022
  30. OOKA T, Raita Y, Fujiogi M, Freishtat RJ, et al
    Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.
    Allergy. 2022 May 27. doi: 10.1111/all.15390.
    PubMed     Abstract available


  31. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
    Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
    Allergy. 2022 May 24. doi: 10.1111/all.15386.
    PubMed    


  32. CARRARO S, di Palmo E, Licari A, Barni S, et al
    Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
    Allergy. 2022 May 23. doi: 10.1111/all.15385.
    PubMed    


  33. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
    RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
    Allergy. 2022 May 20. doi: 10.1111/all.15382.
    PubMed    


  34. LOMMATZSCH M, Suhling H, Korn S, Bergmann KC, et al
    Safety of combining biologics in severe asthma: asthma-related and unrelated combinations.
    Allergy. 2022 May 18. doi: 10.1111/all.15379.
    PubMed    


  35. SOZENER ZC, Cevhertas L, Satitsuksanoa P, van de Veen W, et al
    Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity.
    Allergy. 2022 May 18. doi: 10.1111/all.15378.
    PubMed    


  36. KHALFAOUI L, Symon FA, Couillard S, Hargadon B, et al
    Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma.
    Allergy. 2022 May 17. doi: 10.1111/all.15376.
    PubMed     Abstract available


  37. ACKLAND J, Barber C, Heinson A, Azim A, et al
    NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.
    Allergy. 2022 May 16. doi: 10.1111/all.15375.
    PubMed     Abstract available


  38. XING Y, Wang MH, Leung TF, Wong CK, et al
    Poultry exposure and environmental protection against asthma in rural children.
    Allergy. 2022 May 9. doi: 10.1111/all.15365.
    PubMed     Abstract available


    April 2022
  39. POTAPOVA E, Bordas-Le Floch V, Schlederer T, Vrtala S, et al
    Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
    Allergy. 2022 Apr 26. doi: 10.1111/all.15327.
    PubMed     Abstract available


  40. FARRAIA M, Paciencia I, Mendes FC, Cavaleiro Rufo J, et al
    Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15321.
    PubMed     Abstract available


  41. VAN DER BURG N, Stenberg H, Bjermer L, Diamant Z, et al
    Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15319.
    PubMed    


  42. HARB H, Chatila TA
    Recent Patents in Allergy/Immunology: Method for treating asthma or allergic disease via anti-Notch4 mAb.
    Allergy. 2022 Apr 19. doi: 10.1111/all.15317.
    PubMed    


  43. RASMUSSEN SM, Halvard Hansen ES, Stensrud T, Radon K, et al
    Asthma endotypes in elite athletes: A cross-sectional study of European athletes participating in the Olympic Games.
    Allergy. 2022 Apr 15. doi: 10.1111/all.15313.
    PubMed    


  44. WENG N, Miller M, Pham AK, Komor AC, et al
    Single-base editing of rs12603332 on chromosome 17q21 with a cytosine base editor regulates ORMDL3 and ATF6alpha expression.
    Allergy. 2022;77:1139-1149.
    PubMed     Abstract available


  45. MULLOL J, Laidlaw TM, Bachert C, Mannent LP, et al
    Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Allergy. 2022;77:1231-1244.
    PubMed     Abstract available


    March 2022
  46. FARRAIA M, Paciencia I, Castro Mendes F, Cavaleiro Rufo J, et al
    Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.
    Allergy. 2022 Mar 28. doi: 10.1111/all.15295.
    PubMed     Abstract available


  47. LI Z, Feng Y, Liu H, Yang H, et al
    Single-cell transcriptomics of mouse lung reveal inflammatory memory neutrophils in allergic asthma.
    Allergy. 2022 Mar 21. doi: 10.1111/all.15286.
    PubMed    


  48. PAT Y, Ruckert B, Ogulur I, Yazici D, et al
    Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.
    Allergy. 2022 Mar 10. doi: 10.1111/all.15279.
    PubMed    


  49. RYAN D, Flokstra-de Blok BM, Clark E, Gaudin C, et al
    Allergic and hypersensitivity conditions in non-specialist care: Flow-diagrams to support clinical practice.
    Allergy. 2022 Mar 10. doi: 10.1111/all.15273.
    PubMed     Abstract available


  50. ZUBERBIER T, Abdul Latiff AH, Abuzakouk M, Aquilina S, et al
    The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
    Allergy. 2022;77:734-766.
    PubMed     Abstract available


  51. PAVORD ID, Bel EH, Bourdin A, Chan R, et al
    From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
    Allergy. 2022;77:778-797.
    PubMed     Abstract available


    February 2022
  52. HAAHTELA T, Jantunen J, Saarinen K, Tommila E, et al
    Managing the allergy & asthma epidemic in 2020s - lessons from the Finnish experience.
    Allergy. 2022 Feb 24. doi: 10.1111/all.15266.
    PubMed     Abstract available


  53. SOKOLOWSKA M, Rovati GE, Diamant Z, Untersmayr E, et al
    Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19.
    Allergy. 2022 Feb 16. doi: 10.1111/all.15258.
    PubMed     Abstract available


  54. JUTEL M, Torres MJ, Palomares O, Akdis CA, et al
    COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
    Allergy. 2022 Feb 11. doi: 10.1111/all.15252.
    PubMed    


  55. SOUSA-PINTO B, Fonseca JA, Gemicioglu B, Regateiro FS, et al
    Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma.
    Allergy. 2022 Feb 8. doi: 10.1111/all.15248.
    PubMed    


  56. TANG X, Ronnberg E, Safholm J, Thulasingam M, et al
    Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction.
    Allergy. 2022 Feb 4. doi: 10.1111/all.15245.
    PubMed     Abstract available


  57. CERPS S, Sverrild A, Ramu S, Nieto-Fontarigo JJ, et al
    House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15243.
    PubMed     Abstract available


  58. FIETEN KB, Drijver-Messelink MT, Cogo A, Charpin D, et al
    Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15242.
    PubMed     Abstract available


  59. HAYA LK, Mehri R, Somers-Neal S, Van de Mosselaer S, et al
    Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC).
    Allergy. 2022;77:685-687.
    PubMed    


    January 2022
  60. PARR CL, Nystad W, Karlstad O, Oymar K, et al
    Ten year trends of national healthcare costs of asthma, allergic rhinitis and atopic eczema in 3 million Norwegians.
    Allergy. 2022 Jan 20. doi: 10.1111/all.15225.
    PubMed    


  61. THEOFANI E, Semitekolou M, Samitas K, Mais A, et al
    TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
    Allergy. 2022 Jan 17. doi: 10.1111/all.15221.
    PubMed     Abstract available


  62. NANISHI M, Fujiogi M, Freishtat RJ, Hoptay CE, et al
    Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.
    Allergy. 2022 Jan 9. doi: 10.1111/all.15216.
    PubMed     Abstract available


  63. HUANG Y, Li X, Zhu L, Huang C, et al
    Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
    Allergy. 2022 Jan 7. doi: 10.1111/all.15210.
    PubMed     Abstract available


  64. AGACHE I, Antolin-Amerigo D, de Blay F, Boccabella C, et al
    EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities.
    Allergy. 2022 Jan 2. doi: 10.1111/all.15203.
    PubMed     Abstract available


    December 2021
  65. SOUSA-PINTO B, Filipe Azevedo L, Jutel M, Agache I, et al
    Development and validation of combined symptom-medication scores for allergic rhinitis.
    Allergy. 2021 Dec 21. doi: 10.1111/all.15199.
    PubMed     Abstract available


  66. CORREN J, Pham TH, Gil EG, Salapa K, et al
    Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
    Allergy. 2021 Dec 16. doi: 10.1111/all.15197.
    PubMed     Abstract available


  67. JANSEN K, Satitsuksanoa P, Wirz OF, Schneider SR, et al
    T regulatory cells from atopic asthmatic individuals show a Th2-like phenotype.
    Allergy. 2021 Dec 4. doi: 10.1111/all.15193.
    PubMed    


    November 2021
  68. DELGADO-DOLSET MI, Obeso D, Rodriguez-Coira J, Tarin C, et al
    Understanding uncontrolled severe allergic asthma by integration of omic and clinical data.
    Allergy. 2021 Nov 28. doi: 10.1111/all.15192.
    PubMed     Abstract available


  69. MISHRA A, Majid D, Kandikattu HK, Yadavalli CS, et al
    Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.
    Allergy. 2021 Nov 20. doi: 10.1111/all.15180.
    PubMed     Abstract available


    October 2021
  70. LUNDING LP, Skouras DB, Vock C, Dinarello CA, et al
    The NLRP3 Inflammasome Inhibitor, OLT1177((R)) , Ameliorates Experimental Allergic Asthma in Mice.
    Allergy. 2021 Oct 30. doi: 10.1111/all.15164.
    PubMed    


  71. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
    Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
    Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
    PubMed     Abstract available


  72. SOUSA-PINTO B, Anto JM, Sheikh A, de Lusignan S, et al
    Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England.
    Allergy. 2021 Oct 19. doi: 10.1111/all.15139.
    PubMed    


  73. ADJIBADE M, Davisse-Paturet C, Bernard JY, Adel-Patient K, et al
    Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort.
    Allergy. 2021 Oct 9. doi: 10.1111/all.15137.
    PubMed     Abstract available


  74. PAPI A, Jesenak M, Alfano F, Peroni DG, et al
    The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
    Allergy. 2021 Oct 6. doi: 10.1111/all.15131.
    PubMed     Abstract available


  75. GERTH VAN WIJK R, Dahl R
    Pros and cons: Should AIT be considered in all patients with allergic asthma?
    Allergy. 2021 Oct 4. doi: 10.1111/all.15123.
    PubMed     Abstract available


  76. SMITH AM, Ramirez RM, Harper N, Jimenez F, et al
    Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma.
    Allergy. 2021 Oct 4. doi: 10.1111/all.15124.
    PubMed     Abstract available


  77. KIM JM, Im YN, Chung YJ, Youm JH, et al
    Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
    Allergy. 2021 Oct 3. doi: 10.1111/all.15121.
    PubMed     Abstract available


    September 2021
  78. KIM YC, Choi S, Sohn KH, Bang JY, et al
    Selenomonas: a marker of asthma severity with the potential therapeutic effect.
    Allergy. 2021 Sep 29. doi: 10.1111/all.15114.
    PubMed    


  79. RAIFER H, Schulz AR, Theodorou J, Romero-Olmedo AJ, et al
    Mass cytometry-based identification of a unique T-cell signature in childhood allergic asthma.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15110.
    PubMed    


  80. KHALEVA E, Knibb R, DunnGalvin A, Vazquez-Ortiz M, et al
    Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15109.
    PubMed     Abstract available


    August 2021
  81. JANTUNEN J, Kauppi P, Linna M, Makela M, et al
    Real-world evidence of reduced disability costs during the Finnish Allergy Programme 2008-2018.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15070.
    PubMed    


  82. SCHRODER A, Lunding LP, Zissler UM, Vock C, et al
    IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15072.
    PubMed     Abstract available


  83. ZHAN C, Liu J, Li B, Xu R, et al
    Group 2 Innate Lymphoid Cells in Patients with Non-Asthmatic Eosinophilic Bronchitis.
    Allergy. 2021 Aug 29. doi: 10.1111/all.15068.
    PubMed    


  84. TRAMPER-STRANDERS G, Ambrozej D, Arcolaci A, Atanaskovic-Markovic M, et al
    Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases.
    Allergy. 2021 Aug 13. doi: 10.1111/all.15046.
    PubMed     Abstract available


    June 2021
  85. GIANG N, Mars M, Moreau M, Mejia JE, et al
    Separation of the CaV 1.2-CaV 1.3 calcium channel duo prevents type-2 allergic airway inflammation.
    Allergy. 2021 Jun 28. doi: 10.1111/all.14993.
    PubMed     Abstract available


  86. SIROUX V, Boudier A, Bousquet J, Dumas O, et al
    Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort.
    Allergy. 2021 Jun 25. doi: 10.1111/all.14987.
    PubMed     Abstract available


  87. LOSOL P, Kim SH, Ahn S, Lee S, et al
    Genetic variants in the TLR-related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients.
    Allergy. 2021 Jun 1. doi: 10.1111/all.14970.
    PubMed    


    May 2021
  88. PFAAR O, Bergmann KC, Bonini S, Compalati E, et al
    Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
    Allergy. 2021 May 24. doi: 10.1111/all.14957.
    PubMed     Abstract available


  89. VENTER C, Palumbo MP, Glueck DH, Sauder KA, et al
    The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study.
    Allergy. 2021 May 21. doi: 10.1111/all.14949.
    PubMed     Abstract available


  90. THURMANN L, Herberth G, Seiwert B, Schlittenbauer L, et al
    Prenatal paraben exposure and atopic dermatitis-related outcomes among children.
    Allergy. 2021 May 2. doi: 10.1111/all.14890.
    PubMed     Abstract available


    April 2021
  91. HEMMER W, Sestak-Greinecker G, Braunsteiner T, Wantke F, et al
    Molecularsensitization patterns in animal allergy: relationship with clinical relevance and pet ownership.
    Allergy. 2021 Apr 29. doi: 10.1111/all.14885.
    PubMed     Abstract available


  92. MINDAYE ST, Sun C, Esfahani SAZ, Matsui EC, et al
    Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno-allergomic approach.
    Allergy. 2021 Apr 17. doi: 10.1111/all.14860.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: